Symbol="MRKR"
AssetType="Common Stock"
Name="Marker Therapeutics Inc"
Description="Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, is dedicated to the development and commercialization of various T-cell-based immunotherapies and peptide-based vaccines for the treatment of hematologic malignancies and solid tumor indications. The company is headquartered in Houston, Texas."
CIK="1094038"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="50 N LAURA STREET, SUITE 2500, JACKSONVILLE, FL, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="68631000"
EBITDA="-22172276"
PERatio="None"
PEGRatio="None"
BookValue="1.809"
DividendPerShare="0"
DividendYield="0"
EPS="-3.49"
RevenuePerShareTTM="1.512"
ProfitMargin="-1.955"
OperatingMarginTTM="-1.972"
ReturnOnAssetsTTM="-0.38"
ReturnOnEquityTTM="-0.968"
RevenueTTM="12783600"
GrossProfitTTM="-17125779"
DilutedEPSTTM="-3.49"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="3.909"
AnalystTargetPrice="40"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="3.593"
PriceToBookRatio="1.134"
EVToRevenue="3.641"
EVToEBITDA="-0.472"
Beta="1.142"
num_52WeekHigh="9.3"
num_52WeekLow="0.671"
num_50DayMovingAverage="3.186"
num_200DayMovingAverage="2.723"
SharesOutstanding="8798800"
DividendDate="2016-09-16"
ExDividendDate="None"
symbol="MRKR"
open="8.00"
high="9.30"
low="7.50"
price="8.78"
volume="488583.00"
latest_trading_day="2023-07-25"
previous_close="7.80"
change="0.98"
change_percent="12.5641%"
aroon_positive_momentum_days="33"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Overbought"
value_analysis="Overvalued"
Aroon_change="FALSE"
Aroon_momentum="33"
Volume_recent_avg="590165"
Change_recent_avg="0.06"
Delta_recent_avg="0.33"
Variance_recent_avg="0.17"
Change_ratio_recent_avg="0.57"
RSI_change="TRUE"
ADX_change="FALSE"

event="rsi_change_negative"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="33"
Aroon_momentum_negative="67"
image_negative_thumbnail_id_1="1090"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0123.jpeg"
image_negative_thumbnail_id_2="1132"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0165.jpeg"
image_neutral_thumbnail_id_1="547"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0052.jpeg"
image_neutral_thumbnail_id_2="596"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0003.jpeg"
image_positive_thumbnail_id_1="637"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0071.jpeg"
image_positive_thumbnail_id_2="668"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0040.jpeg"
image_professor_thumbnail_id_1="1186"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
image_professor_thumbnail_id_2="1172"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
